METFORMIN AND INTESTINAL GLUCOSE HANDLING

[11] Pentikainen PJ, Neuivonen PJ, Penttila A, Pharmacokinetics of metformin after intravenous and oral administration to man, Eur J Clin Pharmacol, 16, pp. 195-202, (1979)

[12] Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, Woods HF, Metformin kinetics in healthy subjects and in patients with diabetes mellitus, Br J Clin Pharmacol, 12, pp. 235-246, (1981)

[13] Sirtori CR, Franceschini G, Galli-Kienle M, Cighetta G, Galli G, Disposition of metformin (N, N‐dimethylbiguanide) in man, Clin Pharmacol Ther, 24, pp. 683-693, (1978)

[14] Wilcock C, Bailey CJ, Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, 24, pp. 49-57, (1994)

[15] Hariharan M, Rajhan SS, Srinivasan R, Structure of metformin hydrochloride, Acta Cryst, 45 C, pp. 911-912, (1989)

[16] Schafer G, Guanidines and biguanides, Pharmacology & Therapeutics, 8, pp. 275-295, (1980)

[17] Wilcock C, Wyre N, Bailey CJ, Subcellular distribution of metformin in rat liver, J Pharm Pharmacol, 43, pp. 442-444, (1991)

[18] Caspary WF, Creutzfeldt W, Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of sugar transport, Diabetologia, 7, pp. 379-385, (1971)

[19] Lorch E, Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin diabetic rat, Diabetologia, 7, pp. 195-203, (1971)

[20] Coupar IM, McColl I, Glucose absorption from the rat jejunum during acute exposure to metformin and phenformin, J Pharm Pharmacol, 26, pp. 997-998, (1974)

[11] Pentikainen PJ, Neuivonen PJ, Penttila A, Pharmacokinetics of metformin after intravenous and oral administration to man, Eur J Clin Pharmacol, 16, pp. 195-202, (1979)

[12] Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, Woods HF, Metformin kinetics in healthy subjects and in patients with diabetes mellitus, Br J Clin Pharmacol, 12, pp. 235-246, (1981)

[13] Sirtori CR, Franceschini G, Galli-Kienle M, Cighetta G, Galli G, Disposition of metformin (N, N‐dimethylbiguanide) in man, Clin Pharmacol Ther, 24, pp. 683-693, (1978)

[14] Wilcock C, Bailey CJ, Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, 24, pp. 49-57, (1994)

[15] Hariharan M, Rajhan SS, Srinivasan R, Structure of metformin hydrochloride, Acta Cryst, 45 C, pp. 911-912, (1989)

[16] Schafer G, Guanidines and biguanides, Pharmacology & Therapeutics, 8, pp. 275-295, (1980)

[17] Wilcock C, Wyre N, Bailey CJ, Subcellular distribution of metformin in rat liver, J Pharm Pharmacol, 43, pp. 442-444, (1991)

[18] Caspary WF, Creutzfeldt W, Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of sugar transport, Diabetologia, 7, pp. 379-385, (1971)

[19] Lorch E, Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin diabetic rat, Diabetologia, 7, pp. 195-203, (1971)

[20] Coupar IM, McColl I, Glucose absorption from the rat jejunum during acute exposure to metformin and phenformin, J Pharm Pharmacol, 26, pp. 997-998, (1974)